talquetamab
janssen
['talquetamab', 'monumental-1', 'multiplemyeloma']
#jansen presented the updated results of the monumental-1 trial, a phase 1/2 trial evaluating the efficacy of talquetamab in heavily pretreated #multiplemyeloma patients. #ash22 #ash2022 #bloodmatters #hematology #news #media #oncology #cancer #oncology
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma